Anaerobic coccoid rods belonging to species of Eubacterium and Peptostreptococcus agglutinate more frequently with sera from patients with Crohn's disease than with sera from patients suffering from other diseases and from healthy subjects. Results of agglutination tests with four strains of coccoid anaerobes were used to estimate the probability that a patient suffers from Crohn's disease. The data on healthy subjects and patients with Crohn's disease were subjected to logistic discriminant analysis. With the methods and interpretation described, 52 % of the patients with Crohn's disease were recognized as' definite' or' probable' Crohn's disease and 14 % as 'suspected'. Only 1 % of the healthy subjects were classified as 'suspected' and none as 'definite' or 'probable' Crohn's disease.
INTRODUCTION
Recently, antibodies to anaerobic gram-positive coccoid rods belonging to species of Eubacterium and Peptostreptococcus were found in sera of a considerable percentage of patients with Crohn's disease (Wensinck, 1975 (Wensinck, , 1976 Wensinck & Van De Merwe, 1981) . In healthy subjects and patients with other diseases than Crohn's disease (CD) these antibodies were found less frequently.
Agglutination of four strains of coccoid anaerobes was used to establish the diagnosis of CD. Tests with these strains showed different sensitivities and specificities and a simple interpretation of the agglutination results was not possible. The results with sera from standard groups of patients with CD and of healthy subjects were therefore subjected to discriminant analysis. The methods used and the interpretation of the results in terms of probability that a patient suffers from CD are reported in this paper.
MATERIALS AND METHODS

Agglutination reactions
The techniques used to demonstrate agglutinins to Eubacterium contortum (strains Me 44 and Me 47 ), E. rectale (strain Me 4S ) and Peptostreptococcus productus (strain C 18 ) were described by Wensinck & Van De Merwe (1981) . The results of agglutination reactions were scored as negative (0) or positive (1, 2 or 3, according to strength).
Patients and control subjects
Between 1 Kirsner, 1975) . Patients in whom the differential diagnosis between CD and ulcerative colitis could not be made in the period mentioned were not included. A group of 114 patients with CD was thus collected, 43 men with a median age of 33 years (range 14-68) and 71 women with a median age of 29 years (range 17-74). Forty-three had ileal disease, 25 ileocolonic and 46 colonic disease. Fifty-three patients had undergone intestinal resections. Nineteen patients were taking salicylazosulphapyridine, ten were on corticosteroids and eight on corticosteroid enemas.
The group of healthy subjects consisted of 95 volunteers of the Red Cross Blood Transfusion Service, Rotterdam, 53 male with a median age of 38 years (range 23-64) and 42 female with a median age of 35 years (range 28-62). The agglutination reactions of patients and controls are given in Table 1 .
Statistical methods
The interpretation of any test result rests upon three factors: the initial likelihood that a disease is present on the basis of the clinical evidence at hand (a priori probability) and the likelihood that a given test result occurs in the population with the disease and in that without the disease, respectively. Combining these likelihoods, usually calculated by applying Bayes' theorem, results in the a posteriori probability of the disease. For our results logistic discriminant analysis (Anderson, 1972 ) was used for discrimination between patients with CD and healthy subjects (HS) on the basis of the agglutination reactions. The a posteriori probability of CD can be written as: The estimates 6 0 -6 4 are obtained from the reference samples (n t patients with CD and n, healthy subjects) with a priori probabilities P(CD) and P(HS) proportional to the sample sizes n l and n,: P(CD) = n, P(HS)
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If a posteriori probabilities have to be calculated from other a priori probabilities Q{CD) and #(HS), 6 0 is replaced by d 0 :
(4)
Allocation rules and interpretation
After calculation of the estimated a posteriori probability of CD, several allocation rules can be used. It could be stated, for example, that a subject with agglutination reactions x (= x t ,x t ,x 3 ,x 4 ) is classified as:
When we classify as 'CD' when the a posteriori probability exceeds a certain value say 0-8, and classify as ' non-CD' when the probability is below another value, say 0-2, we have an allocation rule with a region of doubt. Thus:
On the definite CD if 0-99 g P(CD|z) g 1.
RESULTS
Estimation of the coefficients and application of the allocation rules
With the results of the agglutination reactions x x (Me 44 ), x % (C 18 ), x 3 (Me 46 ) and x 4 (Me 47 ) of 114 patients with CD and 95 healthy subjects, the estimates 6 0 -6 4 of the coefficients /? 0~~A m (1) were: 
From (11) it is concluded that coefficients /?rA differ significantly from 0 (a = O05). With the estimated coefficients (9) and (10) a posteriori probabilities were calculated for all possible agglutination reactions ( Table 2 ). The results for the elements from the two samples of patients with CD and healthy subjects are given in Table 3 . When allocation rule (5) is used, classifications are obtained as summarized in Table 4 . If allocation (6) is used, a classification is obtained as given in Table 5 . From this table it is evident that about 20 % of the elements in both samples are not classified. With the use of allocation rule (7) a posteriori probabilities are obviously interpreted more realistically (Table 6 ). In this situation, 42 % of the patients with CD are classified as 'definite CD', 10% as 'probable CD', 14% as 'suspected CD' and 34 % as' no support for CD'. Of the healthy subjects, 99 % are classified in this latter category, whereas only 1% is classified as 'suspected CD' and none as 'probable' or definite CD'.
Verification
The results of allocation were presented for the elements, which were also used for estimation of the coefficients of the logistic function. It would be better to evaluate the classification in new samples from the patients with CD and healthy subjects. As these samples were not available, a split-sample method was used. The sample consisting of 114 patients with CD was randomly divided into two groups of 57 subjects. The sample consisting of 95 healthy subjects was divided into a group of 48 and one of 47 subjects. With the agglutination reactions of the first subsample of 57 patients with CD and 48 healthy subjects, new coefficients were estimated. The results, for equal a priori probabilities were: 
The a posteriori probabilities for the elements of both groups, as determined with these coefficients, are given in Table 7 . From this table it is seen that the results Antibodies and the probability of Crohn's disease 31 
DISCUSSION
With the methods described, 52% of patients with known CD could be recognized with the agglutination reactions as 'definite CD' or 'probable CD'. None of the healthy subjects was classified in these categories. Moreover, 14 % of the patients with CD were classified as 'suspected CD' compared to only 1 % of healthy subjects. About one-third of the patients with CD were classified as "no support for CD' compared to 99°o of healthy subjects. From these results we conclude that application of the agglutination reactions in combination with the interpretation given yields an improvement in discrimination of individuals into groups of patients with CD and healthy subjects. If this system is used for diagnostic purposes, it should discriminate between CD' and non-CD'. The extrapolation from the group 'healthy subjects' to 'non-CD' is only allowed when there are no relevant differences in agglutination reactions between these groups. It has been shown previously that this is true for a large number of 'control' diseases, but in cirrhosis of liver and coeliac disease the results require a different interpretation (Wensinck & Van De Merwe, 1981) .
It should be noted that the test is evaluated with the samples which were also used for estimation of the coefficients of the discriminant function. This difficulty is partly overcome by verification via the split-sample method, but ideally the predictive value of a diagnostic test for clinical use should be evaluated via a comparison of the patient population with a similar population that only differs by the absence of the particular disease. The final classification of patients as 'CD' or 'non-CD', however, requires long-term studies as the average period of time between onset of symptoms of Crohn's disease and diagnosis is 4 years (Dyer & Dawson, 1970; Brandes & Eulenburg. 1976; Mekhjian et al. 1979) .
